Barton A. Kamen
Barton A. Kamen is the Executive Vice President and Chief Medical Officer of the Leukemia and Lymphoma Society. In addition, Dr. Kamen also serves as a Professor of Pediatrics and Pharmacology at the Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA (Volunteer status). Dr. Kamen received his M.D. and Ph.D. degrees from Case Western Reserve University, Cleveland, Ohio, USA, and served his residency and fellowship in pediatrics and pediatric hematology/oncology and pharmacology at Yale University, New Haven, Conn, USA. Dr. Kamen spent three years in Wisconsin, 16 years at the University of Texas Southwestern Medical Center as a Professor of Pediatrics and Pharmacology as the Carl B and Florence E. King Distinguished Professor Pediatrics before becoming the Chief of Pediatric Hematology Oncology and Association Director of the Cancer Institute of New Jersey (1999–2007). During his career, Dr. Kamen has been a recipient of a scholar award from The Leukemia and Lymphoma Society, and other research grants including the Damon Runyon Walter Winchell Fellowship, Burroughs Wellcome Clinical Pharmacology Award, and an American Cancer Society Clinical Research Professorship. He has authored approximately 350 manuscripts (papers and chapters) and is the current Editor-in-Chief of the Journal of Pediatric Hematology Oncology. Dr. Kamen's main laboratory interests are centered around folate and antifolate metabolism, drug development, neurotoxicity from therapy, and metronomic therapy for cancer.
Biography Updated on 27 September 2009